TickerFactsScreenerDevelopers

Transcode Therapeutics, Inc. (RNAZ) — Operating Income

Annual figures by fiscal year, from SEC filings.

2020: -$726.6K2021: -$6.15M2022: -$18.63M2023: -$19.42M2024: -$15.66M2025: -$27.98M-$27.98M
2020Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$27.98M-78.7%
2024-$15.66M+19.4%
2023-$19.42M-4.2%
2022-$18.63M-202.9%
2021-$6.15M-746.6%
2020-$726.6K—